GO:0006383 transcription by RNA polymerase III: RNA Biogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006383 transcription by RNA polymerase III describes the synthesis of RNA from a DNA template by RNA polymerase III, originating at an RNAP III promoter.
• RNA polymerase III produces short, abundant noncoding RNAs including tRNAs, 5S rRNA, U6 snRNA and 7SL RNA that are essential for translation, splicing and protein trafficking.
• Pol III transcription is controlled by promoter architecture, general transcription factors TFIIIA, TFIIIB and TFIIIC, and by chromatin structure.
• Deregulated Pol III transcription is increasingly recognized as a disease factor in cancer, neurodegeneration and infection.
• Pol III can also be recruited to protein-coding gene promoters, expanding its regulatory repertoire beyond classical noncoding RNA genes.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of Pol III subunits and regulators in human cells.
Description
Transcription by RNA polymerase III (Pol III) is the biological process, annotated as GO:0006383, in which RNA polymerase III synthesizes RNA from a DNA template starting at an RNA polymerase III promoter. Unlike RNA polymerase II, which produces long messenger RNAs, Pol III specializes in short, highly abundant noncoding transcripts such as transfer RNAs, 5S ribosomal RNA, U6 small nuclear RNA and 7SL RNA. These products are central to translation, pre-mRNA splicing and protein targeting, making Pol III one of the most transcriptionally active enzymes in proliferating cells. Research over the past decades has moved Pol III from a textbook housekeeping machine to a tightly regulated and disease-relevant system. Its activity is governed by promoter type, by the general transcription factors TFIIIA, TFIIIB and TFIIIC, and by chromatin context. Spatial organization of Pol III transcription within the nucleus further influences its output and coordination with other RNA polymerases. More recently, evidence has shown that Pol III can be recruited to protein-coding gene promoters, suggesting broader regulatory roles than previously appreciated. For biomedical researchers, GO:0006383 provides a precise framework to study RNA biogenesis, translational capacity and stress responses. Because Pol III products set the cell's translational budget, perturbations in this process can drive cancer, neurodegeneration and susceptibility to infection. Understanding the molecular steps, key genes and regulatory inputs of Pol III transcription is therefore essential for functional genomics and therapeutic target discovery.
transcription by RNA polymerase III At A Glance
| GO ID | GO:0006383 |
|---|---|
| GO term | transcription by RNA polymerase III |
| Ontology | biological_process |
| Synonym | transcription from RNA polymerase III promoter; transcription from Pol III promoter; RNA polymerase III transcription factor activity; U6 snRNA transcription (mammalian); U2 snRNA transcription (S. cerevisiae) |
| Major function | Synthesis of short noncoding RNAs such as tRNAs, 5S rRNA, U6 snRNA and 7SL RNA from DNA templates |
| Promoter types | Type 1, type 2 and type 3 Pol III promoters, plus hybrid promoters |
| Core machinery | RNA polymerase III plus general transcription factors TFIIIA, TFIIIB and TFIIIC |
| Regulatory context | Regulated by chromatin structure and contributes to nuclear chromatin organization |
| Disease relevance | Deregulated Pol III transcription acts as a disease factor in cancer, neurodegeneration and infection |
What Is GO:0006383?
In our own words, GO:0006383 transcription by RNA polymerase III is the process in which the enzyme RNA polymerase III reads a DNA template and synthesizes an RNA molecule, beginning at a promoter recognized by the Pol III machinery. This definition covers transcription from all canonical Pol III promoter types, including type 1, type 2 and type 3 promoters, as well as hybrid promoters, and it encompasses the synthesis of short noncoding RNAs such as tRNAs, 5S rRNA, U6 snRNA and related transcripts.
Why Is transcription by RNA polymerase III Important in Cell Biology?
GO:0006383 is important because Pol III transcription supplies the cell with the short noncoding RNAs that underpin translation, splicing and protein trafficking, and because its dysregulation is now recognized as a direct contributor to human disease. Studying this process helps researchers understand how cells match translational capacity to growth signals, how chromatin and promoter architecture control polymerase recruitment, and how pathogens or oncogenes hijack Pol III output.
• Pol III products such as tRNAs and 5S rRNA are rate-limiting for ribosome assembly and protein synthesis.
• U6 snRNA produced by Pol III is a core component of the spliceosome, linking GO:0006383 to pre-mRNA splicing.
• 7SL RNA produced by Pol III is required for the signal recognition particle and protein targeting.
• Pol III transcription is regulated by promoter type and chromatin structure, making it a model for studying gene regulation.
• Deregulated Pol III transcription is a recognized disease factor in cancer and other pathologies.
• Pol III transcription-associated polyadenylation can promote accumulation of noncoding retrotransposons during infection.
• Spatial organization of Pol III transcription within the nucleus affects its coordination with other nuclear processes.
• Evidence of Pol III recruitment at protein-coding gene promoters expands its functional repertoire.
• Pol III subunits and regulators are tractable CRISPR targets for functional genomics and drug discovery.
What Happens During transcription by RNA polymerase III?
Promoter recognition and pre-initiation complex assembly
In simple terms: First, the cell's transcription machinery finds the right starting point on the DNA and assembles there.
Transcription by RNA polymerase III begins with recognition of an RNAP III promoter, which can be a type 1, type 2 or type 3 promoter, or a hybrid promoter. Type 2 promoters, typical of tRNA genes, are recognized by TFIIIC, which in turn recruits TFIIIB; type 1 promoters, such as the 5S rRNA gene, require TFIIIA to recruit TFIIIC and then TFIIIB. TFIIIB, composed of TBP, Brf1 and Bdp1, positions RNA polymerase III over the transcription start site to form the pre-initiation complex. This ordered assembly is a defining feature of GO:0006383 and is regulated by promoter architecture and chromatin context.
Initiation and promoter escape
In simple terms: Once assembled, the polymerase opens the DNA and starts making RNA.
After the pre-initiation complex is formed, RNA polymerase III initiates RNA synthesis at the transcription start site defined by the Pol III promoter. Initiation requires the catalytic activity of the polymerase and is coupled to promoter escape, during which TFIIIB remains bound to facilitate multiple rounds of transcription. The efficiency of initiation and escape is influenced by the promoter type and by the chromatin environment surrounding the template.
Elongation and termination
In simple terms: The polymerase then travels along the DNA, building the RNA chain until it reaches a stop signal.
During elongation, RNA polymerase III processively extends the RNA transcript using the DNA template. Pol III transcription typically terminates at short runs of thymidine residues in the template, releasing the RNA product. The resulting transcripts are short and abundant, consistent with the noncoding RNA products of GO:0006383 such as tRNAs, 5S rRNA and U6 snRNA. Recent work has also shown that Pol III transcription can be associated with polyadenylation, which promotes accumulation of noncoding retrotransposons during infection.
Nuclear spatial organization and coordination
In simple terms: This transcription does not happen randomly in the nucleus; it is organized in specific locations.
Pol III transcription is spatially organized within the nucleus, with components and active genes concentrated in specific nuclear domains. This organization facilitates efficient recycling of transcription factors and coordination with other RNA polymerases and processing machineries. Chromatin structure both regulates Pol III transcription and is in turn influenced by it, linking GO:0006383 to nuclear chromatin organization. More recently, evidence has shown that Pol III can be recruited to protein-coding gene promoters, indicating that its spatial and functional repertoire extends beyond classical Pol III genes.
Key Genes Involved in GO:0006383 transcription by RNA polymerase III
The following genes and proteins are central to transcription by RNA polymerase III (GO:0006383), based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR3A | Catalytic subunit of RNA polymerase III | Core enzyme for all Pol III transcription; target for functional studies |
| POLR3B | Second largest subunit of RNA polymerase III | Essential for catalytic activity and assembly |
| POLR3C | Subunit of RNA polymerase III | Contributes to enzyme stability and promoter engagement |
| POLR3D | Subunit of RNA polymerase III | Part of the core Pol III complex |
| POLR3E | Subunit of RNA polymerase III | Involved in transcription initiation and elongation |
| POLR3F | Subunit of RNA polymerase III | Required for Pol III assembly and activity |
| POLR3G | Subunit of RNA polymerase III | Linked to Pol III regulation and proliferation |
| POLR3H | Subunit of RNA polymerase III | Core component of the enzyme |
| POLR3K | Subunit of RNA polymerase III | Contributes to transcription termination and RNA cleavage |
| Gtf3a (TFIIIA) | Type 1 promoter recognition factor | Required for 5S rRNA gene transcription |
| Gtf3b (TFIIIB) | Recruits Pol III to promoters | Central initiation factor for Pol III transcription |
| Gtf3c (TFIIIC) | Recognizes type 2 promoters | Assembly factor for pre-initiation complex |
| Bdp1 | Subunit of TFIIIB | Required for Pol III recruitment and initiation |
| Brf1 | Subunit of TFIIIB | Essential for Pol III initiation |
| TBP | TATA-binding protein in TFIIIB | Shared factor linking Pol II and Pol III transcription |
| Maf1 | Negative regulator of Pol III transcription | Represses Pol III under stress and nutrient limitation |
| MYC | Oncogenic regulator of Pol III output | Drives Pol III transcription in cancer |
How Is transcription by RNA polymerase III Regulated?
Transcription by RNA polymerase III is regulated at multiple levels, including promoter architecture, general transcription factor availability and chromatin structure. Chromatin organization both controls Pol III transcription and is influenced by it, creating a feedback relationship between transcription and nuclear architecture. Pol III output is also responsive to cellular growth and stress signals, and its deregulation is recognized as a disease factor. In infection settings, Pol III transcription-associated polyadenylation can promote accumulation of noncoding retrotransposons, illustrating how regulatory context shapes Pol III products.
transcription by RNA polymerase III and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLR3A | Pol III transcription dysfunction linked to disease pathology | Knockout and point-mutation cell models |
| POLR3B | Pol III transcription dysfunction linked to disease pathology | Knockout and knock-in cell models |
| MYC | Oncogenic activation of Pol III output | Overexpression and knockout models |
| Maf1 | Negative regulation of Pol III in stress and disease | Knockout and overexpression models |
| POLR3G | Pol III regulation in proliferation and disease | Knockout and tagged knock-in models |
RNA polymerase III transcription as a disease factor
Deregulated RNA polymerase III transcription is increasingly recognized as a disease factor, contributing to pathological states such as cancer and other proliferative disorders. Because Pol III products set translational capacity, changes in Pol III activity can alter the cell's biosynthetic output and support abnormal growth. This makes GO:0006383 a relevant process for understanding disease mechanisms and for identifying therapeutic vulnerabilities.
Infection and retrotransposon accumulation
During infection, Pol III transcription-associated polyadenylation promotes the accumulation of noncoding retrotransposons, linking GO:0006383 to host-pathogen interactions and genome stability. This finding expands the disease relevance of Pol III transcription beyond classical proliferative disorders and highlights its role in stress and infection responses.
Neurodegeneration and transcriptional stress
Altered regulation of Pol III transcription has been discussed in the context of pathology, including neurodegenerative conditions where transcriptional stress and RNA processing defects contribute to disease. The precise mechanisms continue to be investigated, but the connection between Pol III regulation and cellular homeostasis is well supported.
From transcription by RNA polymerase III-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a Pol III subunit required for tRNA and 5S rRNA synthesis? | CRISPR knockout of POLR3A, POLR3B or POLR3C |
| Does a point mutation in a Pol III subunit alter transcription activity? | CRISPR point-mutation knock-in of POLR3A or POLR3B |
| Where does Pol III localize and assemble in the nucleus? | Tagged knock-in of Pol III subunits for imaging |
| Does overexpression of a regulator increase Pol III output? | Overexpression of MYC or other regulators |
| Does loss of Maf1 derepress Pol III transcription? | Maf1 knockout cells |
| Is Pol III recruited to protein-coding gene promoters? | Knock-in tagging and chromatin assays at coding promoters |
How to Study the transcription by RNA polymerase III Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels including Pol III products | Assessing changes in tRNA and 5S rRNA after perturbation |
| Small RNA sequencing | Short noncoding RNA species | Profiling Pol III transcripts such as U6 snRNA |
| ChIP-seq | Occupancy of Pol III and transcription factors on DNA | Mapping promoters and recruitment sites |
| CLIP or related methods | RNA binding by Pol III machinery | Studying RNA processing and termination |
| Live-cell imaging | Localization and dynamics of tagged Pol III subunits | Nuclear spatial organization studies |
| Proteomics | Protein composition of Pol III complexes | Identifying subunits and interactors |
| Reporter assays | Promoter-driven transcription activity | Testing promoter types and mutations |
| CRISPR screening | Gene requirements for Pol III output | Identifying regulators of GO:0006383 |
RNA-seq and small RNA profiling
RNA sequencing and small RNA profiling can quantify Pol III products such as tRNAs, 5S rRNA and U6 snRNA, providing a readout of GO:0006383 activity. These methods are widely used to assess how genetic perturbations alter Pol III output.
Chromatin immunoprecipitation and occupancy mapping
Chromatin immunoprecipitation followed by sequencing can map the occupancy of Pol III and its general transcription factors at promoters, revealing where transcription initiates and how it is organized. Such approaches have been used to show Pol III recruitment at protein-coding gene promoters.
Imaging and spatial organization
Imaging approaches reveal the spatial organization of Pol III transcription within the nucleus, showing that components concentrate in specific domains. Tagged knock-in of Pol III subunits enables live-cell and fixed-cell imaging of assembly and localization.
Biochemical and proteomic analysis
Biochemical purification and proteomic analysis of Pol III and its associated factors define the composition of the transcription machinery and its interactions. These methods help identify subunits and regulators relevant to GO:0006383.
How CRISPR Can Be Used to Study GO:0006383 transcription by RNA polymerase III
Knockout
CRISPR knockout of Pol III subunits or regulators can abolish or reduce transcription by RNA polymerase III, allowing researchers to test which components are essential for tRNA, 5S rRNA and U6 snRNA production. Knockout of negative regulators such as Maf1 can derepress Pol III output, providing a complementary approach to study regulation.
Point Mutation
CRISPR point-mutation knock-in can introduce specific amino acid changes into Pol III subunits to dissect catalytic activity, promoter recognition or factor interactions without eliminating the protein. Such models are valuable for linking structural features to transcription phenotypes.
Knock-in
Tagged knock-in of Pol III subunits or transcription factors enables imaging, affinity purification and chromatin occupancy studies, revealing where and when GO:0006383 occurs in the nucleus. Knock-in reporters at Pol III promoters can also provide sensitive readouts of transcription activity.
Overexpression
CRISPR-mediated overexpression of Pol III regulators such as MYC can increase Pol III output and model disease-associated activation. Overexpression models help determine whether a candidate regulator is sufficient to drive transcription by RNA polymerase III.
How EDITGENE Supports transcription by RNA polymerase III Research
Researchers studying transcription by RNA polymerase III-related genes often need to determine whether a candidate gene is causally involved in Pol III output, how specific mutations affect enzyme function, and where the machinery acts within the nucleus. EDITGENE provides the CRISPR cell models and screening services needed to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for transcription by RNA polymerase III research.
Frequently Asked Questions About transcription by RNA polymerase III
What is transcription by RNA polymerase III?
Transcription by RNA polymerase III (GO:0006383) is the synthesis of RNA from a DNA template by RNA polymerase III, starting at an RNAP III promoter.
What genes are involved in transcription by RNA polymerase III?
Key genes include POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K, Gtf3a, Gtf3b, Gtf3c, Brf1, Bdp1 and TBP, as well as regulators such as Maf1 and MYC.
What RNAs are made by RNA polymerase III?
Pol III produces short noncoding RNAs including tRNAs, 5S rRNA, U6 snRNA and 7SL RNA.
What are the promoter types for RNA polymerase III?
Pol III promoters include type 1, type 2 and type 3 promoters, as well as hybrid promoters.
How is transcription by RNA polymerase III regulated?
It is regulated by promoter architecture, general transcription factors TFIIIA, TFIIIB and TFIIIC, and by chromatin structure.
Why is RNA polymerase III transcription important in disease?
Deregulated Pol III transcription is recognized as a disease factor, contributing to cancer and other pathologies.
Can RNA polymerase III transcribe protein-coding genes?
Evidence shows that Pol III can be recruited to protein-coding gene promoters, expanding its functional repertoire.
What is the role of TFIIIB in Pol III transcription?
TFIIIB recruits RNA polymerase III to promoters and is essential for initiation of transcription.
How can CRISPR be used to study transcription by RNA polymerase III?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of Pol III subunits and regulators.
What methods measure RNA polymerase III transcription?
RNA-seq, small RNA sequencing, ChIP-seq, imaging and proteomics are commonly used to measure and map Pol III transcription.
Conclusion
GO:0006383 transcription by RNA polymerase III is a fundamental biological process that supplies the cell with short noncoding RNAs essential for translation, splicing and protein targeting. Its regulation by promoter type, transcription factors and chromatin, together with its emerging roles at protein-coding promoters and in disease, makes it a rich area for functional genomics. By combining precise CRISPR models with RNA-seq, ChIP-seq and imaging readouts, researchers can dissect the molecular logic of Pol III transcription and its contributions to human disease. EDITGENE supports these efforts with knockout, point-mutation, knock-in, overexpression and library screening services tailored to GO:0006383.
References
- 1. Schwartz AM et al.. 2024. [Regulation of Transcription by RNA Polymerase III Promotors in the Norm and Pathology].. Mol Biol (Mosk) 58(2):220-233 PMID: 39355880
- 2. Yeganeh M et al.. 2020. RNA polymerase III transcription as a disease factor.. Genes Dev 34(13-14):865-882 PMID: 32611613
- 3. Turowski TW et al.. 2016. Transcription by RNA polymerase III: insights into mechanism and regulation.. Biochem Soc Trans 44(5):1367-1375 PMID: 27911719
- 4. Geiduschek EP et al.. 1988. Transcription by RNA polymerase III.. Annu Rev Biochem 57:873-914 PMID: 3052292
- 5. Lari A et al.. 2025. RNA polymerase III transcription-associated polyadenylation promotes the accumulation of noncoding retrotransposons during infection.. Proc Natl Acad Sci U S A 122(32):e2507186122 PMID: 40768347
- 6. Pascali C et al.. 2013. RNA polymerase III transcription - regulated by chromatin structure and regulator of nuclear chromatin organization.. Subcell Biochem 61:261-87 PMID: 23150255
- 7. Haeusler RA et al.. 2006. Spatial organization of transcription by RNA polymerase III.. Nucleic Acids Res 34(17):4826-36 PMID: 16971453
- 8. K C R et al.. 2024. Evidence of RNA polymerase III recruitment and transcription at protein-coding gene promoters.. Mol Cell 84(21):4111-4124.e5 PMID: 39393362
